Diet Soda Consumption is Associated with Shifts in Gut Microbiome Function of Overweight Young Women
Background: Low-calorie sweeteners (LCS) are consumed as sugar substitutes and may alter gut microbial composition. Their effects on microbial functional pathways and cardiometabolic physiology in humans remain poorly understood, particularly among individuals with overweight. Methods: We conducted a secondary analysis of an 8-week, single-arm pre/post intervention involving eight overweight young adult women who consumed sucralose- and acesulfame-potassium-sweetened Diet Pepsi three times daily. Shotgun metagenomic sequencing of stool samples was used to profile microbial functional pathways with HUMAnN2. Multivariable linear mixed models (MaAsLin2) assessed associations between pathways and metabolic biomarkers. We hierarchically clustered nominally significant pathways into six representative groups and calculated Spearman correlations with interleukin-6 (IL-6), leptin, and HOMA-IR. P values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) procedure. Biomarkers were measured using clinical chemistry and immunoassays. Results: MaAsLin2 identified 33 microbial pathways nominally associated with the intervention (exploratory FDR ≤ 0.25); one pathway (PWY-5104) also met the conventional FDR ≤ 0.10 threshold. Eighteen pathways were upregulated and 15 downregulated, with log fold changes ranging from −2.47 to 3.18. The 33 pathways were grouped into six functional clusters. L-alanine biosynthesis (PWY0-1061) was positively correlated with circulating IL-6 (ρ = 0.74; q < 0.01). Phosphopantothenate biosynthesis I (PANTO-PWY) was not significantly correlated with IL-6 (ρ = −0.46; q = 0.22). Conclusion: Gut microbial functional analysis identified a positive association between L-alanine biosynthesis and circulating IL-6. This finding complements previously reported taxonomic shifts in this cohort and suggests a potential relationship between LCS consumption, microbial function, and host inflammatory signaling.
Authors
- Marcos Pérez‐Losada (ORCID: https://orcid.org/0000-0002-2585-4657)
- Carmen P. Ortega‐Santos (ORCID: https://orcid.org/0000-0002-0071-1190)
- Keith A. Crandall (ORCID: https://orcid.org/0000-0002-0836-3389)
- Allison Cara Sylvetsky (ORCID: https://orcid.org/0000-0003-0424-2798)
- Philip Yamoah Appiah (ORCID: https://orcid.org/0009-0002-0706-2506)
Institutions
- University of Rhode Island (US)
- George Washington University (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-15
- DOI
- https://doi.org/10.64898/2026.11.12.26367968
- Primary Topic
- Gut microbiota and health
- Type
- preprint